Improving Access To Psychological Treatment And The Mental Health Of Australians With Chronic Physical Disease.
Funder
National Health and Medical Research Council
Funding Amount
$425,048.00
Summary
Most Australians will have to manage one or more chronic health conditions in their lifetime. Poor mental health is known to significantly compromise the medical treatment, self-management and, thus, the prognosis of adults with chronic physical disease. The proposed fellowship seeks to address three critical knowledge gaps limiting our ability to support the mental health of Australians with chronic physical diseases.
Advanced Population-based Methods To Evaluate And Inform Immunisation Policy And Practice
Funder
National Health and Medical Research Council
Funding Amount
$425,048.00
Summary
Despite the overall success of immunisation programs, preventable infections continue to occur, with Aboriginal children suffering the most. I will study the health and vaccination records for 1.95 million children (98,000 Aboriginal) in New South Wales and Western Australia to see who is most at risk of vaccine preventable infections and why. The findings will aid development of strategies to target high-risk children and to optimise the benefits obtained from Australia’s immunisation program.
The mortality rate from community-acquired pneumonia has not improved over the past four decades. New pulmonary infectious diseases such as due to non tuberculous mycobacteria are causing increasing problems and bronchiectasis is responsible for an ever increasing mortality, morbidity and economic burden on our health system. This grant will support Professor Waterer in continuing to reduce the personal and society burden of pulmonary infections.
Cognitive Phenotyping And Personalised Treatment For Methamphetamine Addiction
Funder
National Health and Medical Research Council
Funding Amount
$483,402.00
Summary
Prevention and treatment of addiction to stimulants such as methamphetamine is imperative for community health and safety. This fellowship will enable me to apply my expertise in impulsivity and addiction to identify people at risk of increasing methamphetamine use and to develop and evaluate cognitive training therapies that will empower people with methamphetamine related problems to control their drug use. Outcomes include a risk identification and triage tool and three novel therapies.
Mood and anxiety disorders represent a tremendous cause of disability and morbidity. This research will use cutting-edge brain imaging technologies to understand why these disorders typically emerge in young people and whether brain imaging can reliably predict the effectiveness of different treatments for individual patients.
Extinguishing Fearful And Addictive Brain During Adolescence
Funder
National Health and Medical Research Council
Funding Amount
$428,437.00
Summary
Exposure therapies rely on the decrease in emotions to previous triggers due to the exposure to those triggers without an emotional event in a safe environment. Adolescence marks a period of maturation that is particularly resistant to such therapies, due to the imbalance of different receptors in their prefrontal cortex. We will redress such chemical imbalance by using existing clinically-approved drugs, and facilitate behavioural therapies to treat adolescent anxiety and substance abuse.
An In Depth Analysis Of Clinical And Virological Outcomes Of 2 Strategies For The Antiretroviral Salvage Of First-line Regimen Virological Failure For HIV-1 Infection Tested In An Australian-led Randomised, International, Multi-centre Clinical Trial
Funder
National Health and Medical Research Council
Funding Amount
$421,747.00
Summary
The recently completed Australian-led SECOND-LINE trial is the first high quality study to provide reliable evidence for policy recommendations for the composition of anti-HIV drug cocktails after standard initial treatment has failed. This award will support the researcher in further refining our understanding of how to manage second-line therapy including proposals to test the use of low-cost technologies for application in resource-limited settings where the majority of people with HIV live.